| Bioactivity | Irucalantide is kallikrein inhibitor[1]. |
| Target | kallikrein |
| Name | Irucalantide |
| CAS | 1631160-47-8 |
| Formula | C76H106N20O18S3 |
| Molar Mass | 1683.97 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Teufel DP, et al. Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema. J Med Chem. 2018 Apr 12;61(7):2823-2836. |